Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 3OTHER_GOV 1INDUSTRY 1

Study Type

Observational 1

Sponsor

Conditions

Rheumatic Diseases 1Nervous System Diseases 1Hematologic Diseases 1COVID-19 1

Interventions

Gemcitabine 15Cisplatin 12Radiotherapy 11Metformin 8Fluorouracil 8Capecitabine 8Paclitaxel 7Oxaliplatin 7Exercise 7Indocyanine Green 6Docetaxel 6Cyclophosphamide 6Control Groups 6Surveys and Questionnaires 5Standard of Care 5Nivolumab 5Letrozole 5Irinotecan 5pembrolizumab 4durvalumab 4Zoledronic Acid 4Vinorelbine 4Saline Solution 4Preoperative Exercise 4Magnetic Resonance Spectroscopy 4Leucovorin 4Ifosfamide 4Gefitinib 4Drug Therapy 4Carboplatin 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × OTHER_GOV × COVID-19 Vaccines × Clear all
NCT04848493 2025-06-13

VAX4FRAIL

Azienda USL Reggio Emilia - IRCCS

Completed
747 enrolled

COVID-19, Hematologic Diseases, Nervous System Diseases, Rheumatic Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡